Promising Pharmaceutical Stocks To Follow Today - August 7th

Key Points

• Eli Lilly and Company currently has a market capitalization of $611.73 billion and is seeing significant trading activity, with volumes exceeding its average by over six times on August 7th.
• Novo Nordisk A/S recently traded at $48.88, showing a notable increase, and has a market capitalization of $218.23 billion with a 12-month trading range between $45.05 and $139.74.
• McKesson Corporation operates a diversified business model across multiple healthcare segments and reported a stock price of $660.53, with a market cap of $82.64 billion.

Eli Lilly and Company, Novo Nordisk A/S, McKesson, Vertex Pharmaceuticals, and D-Wave Quantum are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in researching, developing, manufacturing and marketing prescription drugs, vaccines and other medical therapies. Investors in these companies gain exposure to an industry driven by scientific innovation and patent-protected revenue streams. However, pharmaceutical stocks can be volatile, as their performance often hinges on clinical trial results, regulatory approvals and patent expirations. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded down $100.91 during mid-day trading on Thursday, reaching $645.46. The stock had a trading volume of 23,219,112 shares, compared to its average volume of 3,935,010. The stock has a 50-day simple moving average of $777.97 and a two-hundred day simple moving average of $800.20. The stock has a market capitalization of $611.73 billion, a PE ratio of 52.46, a P/E/G ratio of 1.09 and a beta of 0.44. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.37 and a quick ratio of 1.06. Eli Lilly and Company has a 12 month low of $633.20 and a 12 month high of $972.53.

Read Our Latest Research Report on LLY

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NVO stock traded up $3.50 during trading on Thursday, reaching $48.88. 36,596,081 shares of the company were exchanged, compared to its average volume of 11,222,478. Novo Nordisk A/S has a twelve month low of $45.05 and a twelve month high of $139.74. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.74 and a quick ratio of 0.56. The company has a market capitalization of $218.23 billion, a price-to-earnings ratio of 14.45, a P/E/G ratio of 1.43 and a beta of 0.63. The company has a 50-day moving average of $67.96 and a two-hundred day moving average of $72.01.

Read Our Latest Research Report on NVO

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

NYSE MCK traded down $43.23 on Thursday, hitting $660.53. The company's stock had a trading volume of 1,596,650 shares, compared to its average volume of 887,564. The firm has a market cap of $82.64 billion, a PE ratio of 25.59, a PEG ratio of 1.43 and a beta of 0.50. The company's 50-day moving average is $716.13 and its 200 day moving average is $678.04. McKesson has a 1-year low of $464.42 and a 1-year high of $737.89.

Read Our Latest Research Report on MCK

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor.

NASDAQ VRTX traded down $9.75 on Thursday, reaching $375.90. The company had a trading volume of 2,799,358 shares, compared to its average volume of 1,617,728. The firm has a market cap of $96.53 billion, a price-to-earnings ratio of 26.90 and a beta of 0.44. The business has a 50 day moving average of $453.73 and a two-hundred day moving average of $466.25. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.52 and a quick ratio of 2.29. Vertex Pharmaceuticals has a fifty-two week low of $372.35 and a fifty-two week high of $519.88.

Read Our Latest Research Report on VRTX

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of NYSE:QBTS traded down $0.54 during trading on Thursday, reaching $17.04. The stock had a trading volume of 58,346,532 shares, compared to its average volume of 69,377,047. D-Wave Quantum has a 52 week low of $0.75 and a 52 week high of $20.56. The firm's fifty day moving average is $16.68 and its 200 day moving average is $10.95. The stock has a market cap of $4.98 billion, a price-to-earnings ratio of -28.46 and a beta of 1.41. The company has a debt-to-equity ratio of 0.15, a quick ratio of 20.61 and a current ratio of 20.73.

Read Our Latest Research Report on QBTS

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.